Digital Diabetes Management Market Size, Share, Trends, Growth and Forecast Report 2021-2027

Description

The global Digital Diabetes Management market garnered revenue around USD 5,478.9 million in 2020 and projected to reach USD 19,139.9 million in 2027, with at a compound annual growth rate (CAGR) 23.6% throughout the estimate period from 2021 to 2027. The digital diabetes management system is helping patients for improving self-management and control the condition. Reduction of blood glucose level and sustaining lower blood glucose is one of the major challenges in managing diabetes. Thus, digital engagement can play a significant role in providing proper care for patients suffering from diabetes 1 and 2.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Digital Diabetes Management market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Digital Diabetes Management market growth.

The global Digital Diabetes Management market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

The report provides a comprehensive analysis of the key players operating in the global digital diabetes management market, which include Abbott laboratories, ACON Laboratories, Inc., Bayer AG, Becton, Dickinson and Company, Dexcom, Inc, F. Hoffmann-La Roche Ltd., Johnson and Johnson, Medtronic Plc., Novo Nordisk A/S and Terumo corporation among others.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

By Type 

·         Handheld Devices

·         Wearable Devices

By Product

·         Smart Glucose Meter

·         Smart Insulin Pumps

·         Smart Insulin Pens

·         Apps  

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

 

North America

United States

Canada

 

Europe

Germany

United Kingdom

Italy

France

Rest of EU

 

Asia Pacific

China

India

Japan

Southeast Asia

Rest of APAC

 

Central & South America 

Brazil 

Argentina

Rest of Central & South America 

 

Middle East and Africa

GCC

North Africa

South Africa 

TABLE OF CONTENT

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Digital Diabetes Management Market, By Type

7.1.  Digital Diabetes Management Market, by Type, 2021-2027

7.1.1.    Handheld Devices

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Wearable Devices

7.1.2.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global Digital Diabetes Management Market, By Product

8.1.  Digital Diabetes Management Market, by Product, 2021-2027

8.1.1.    Smart Glucose Meter

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Smart Insulin Pumps

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Smart Insulin Pens

8.1.3.1.        Market Revenue and Forecast (2016-2027)

8.1.4.    Apps

8.1.4.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global Digital Diabetes Management Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Type (2016-2027)

9.1.2.    Market Revenue and Forecast, by Product (2016-2027)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Type (2016-2027)

9.1.3.2.        Market Revenue and Forecast, by Product (2016-2027)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Type (2016-2027)

9.1.4.2.        Market Revenue and Forecast, by Product (2016-2027)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Type (2016-2027)

9.2.2.    Market Revenue and Forecast, by Product (2016-2027)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Type (2016-2027)

9.2.3.2.        Market Revenue and Forecast, by Product (2016-2027)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Type (2016-2027)

9.2.4.2.        Market Revenue and Forecast, by Product (2016-2027)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Type (2016-2027)

9.2.5.2.        Market Revenue and Forecast, by Product (2016-2027)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Type (2016-2027)

9.2.6.2.        Market Revenue and Forecast, by Product (2016-2027)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Type (2016-2027)

9.3.2.    Market Revenue and Forecast, by Product (2016-2027)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Type (2016-2027)

9.3.3.2.        Market Revenue and Forecast, by Product (2016-2027)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Type (2016-2027)

9.3.4.2.        Market Revenue and Forecast, by Product (2016-2027)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Type (2016-2027)

9.3.5.2.        Market Revenue and Forecast, by Product (2016-2027)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Type (2016-2027)

9.3.6.2.        Market Revenue and Forecast, by Product (2016-2027)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Type (2016-2027)

9.4.2.    Market Revenue and Forecast, by Product (2016-2027)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Type (2016-2027)

9.4.3.2.        Market Revenue and Forecast, by Product (2016-2027)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Type (2016-2027)

9.4.4.2.        Market Revenue and Forecast, by Product (2016-2027)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Type (2016-2027)

9.4.5.2.        Market Revenue and Forecast, by Product (2016-2027)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Type (2016-2027)

9.4.6.2.        Market Revenue and Forecast, by Product (2016-2027)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Type (2016-2027)

9.5.2.    Market Revenue and Forecast, by Product (2016-2027)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Type (2016-2027)

9.5.3.2.        Market Revenue and Forecast, by Product (2016-2027)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Type (2016-2027)

9.5.4.2.        Market Revenue and Forecast, by Product (2016-2027)

Chapter 10.  Company Profiles

10.1.              Abbott laboratories

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              ACON Laboratories, Inc.

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Bayer AG

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Becton

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Dickinson and Company

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Dexcom, Inc

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              F. Hoffmann-La Roche Ltd.

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Johnson and Johnson

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Medtronic Plc.

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Novo Nordisk A/S

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

10.11.           Terumo corporation among others.

10.11.1.               Company Overview

10.11.2.               Product Offerings

10.11.3.               Financial Performance

10.11.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

12.2.              Glossary of Terms

Choose License Type

Checkout Inquiry Sample